| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 40 | 2023 | 364 | 4.780 |
Why?
|
| Cardiac Surgical Procedures | 40 | 2022 | 505 | 4.210 |
Why?
|
| Loeys-Dietz Syndrome | 13 | 2023 | 21 | 3.370 |
Why?
|
| Aortic Valve | 18 | 2024 | 250 | 3.230 |
Why?
|
| Heart Transplantation | 17 | 2021 | 814 | 2.530 |
Why?
|
| Pulmonary Valve | 8 | 2024 | 34 | 2.350 |
Why?
|
| Blood Vessel Prosthesis Implantation | 16 | 2019 | 235 | 2.330 |
Why?
|
| Infant | 58 | 2022 | 3156 | 1.860 |
Why?
|
| Ductus Arteriosus, Patent | 6 | 2022 | 45 | 1.840 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2024 | 77 | 1.760 |
Why?
|
| Cardiopulmonary Bypass | 15 | 2020 | 160 | 1.760 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2024 | 128 | 1.720 |
Why?
|
| Heart Valve Prosthesis Implantation | 11 | 2021 | 186 | 1.670 |
Why?
|
| Aortic Aneurysm, Thoracic | 10 | 2021 | 97 | 1.660 |
Why?
|
| Child | 61 | 2024 | 7273 | 1.600 |
Why?
|
| Marfan Syndrome | 13 | 2023 | 27 | 1.600 |
Why?
|
| Child, Preschool | 46 | 2021 | 3781 | 1.410 |
Why?
|
| Aorta | 9 | 2022 | 273 | 1.350 |
Why?
|
| Aortic Aneurysm | 9 | 2019 | 70 | 1.340 |
Why?
|
| Infant, Newborn | 37 | 2024 | 2427 | 1.270 |
Why?
|
| Aorta, Thoracic | 10 | 2023 | 148 | 1.270 |
Why?
|
| Reoperation | 20 | 2024 | 696 | 1.170 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2024 | 216 | 1.140 |
Why?
|
| Heart Valve Diseases | 3 | 2024 | 100 | 1.120 |
Why?
|
| Norwood Procedures | 4 | 2024 | 40 | 1.110 |
Why?
|
| Replantation | 6 | 2018 | 35 | 1.110 |
Why?
|
| Vascular Surgical Procedures | 8 | 2021 | 151 | 1.040 |
Why?
|
| Humans | 148 | 2024 | 93138 | 1.010 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2024 | 61 | 1.010 |
Why?
|
| Retrospective Studies | 45 | 2024 | 10132 | 0.940 |
Why?
|
| Aortic Valve Stenosis | 3 | 2024 | 146 | 0.940 |
Why?
|
| Tetralogy of Fallot | 6 | 2022 | 47 | 0.930 |
Why?
|
| Postoperative Complications | 23 | 2020 | 2552 | 0.900 |
Why?
|
| Treatment Outcome | 34 | 2024 | 9074 | 0.880 |
Why?
|
| Vascular Grafting | 2 | 2017 | 18 | 0.880 |
Why?
|
| Male | 84 | 2024 | 44360 | 0.870 |
Why?
|
| Pulmonary Artery | 10 | 2022 | 333 | 0.870 |
Why?
|
| Saphenous Vein | 3 | 2012 | 59 | 0.870 |
Why?
|
| Female | 92 | 2023 | 48547 | 0.850 |
Why?
|
| Risk Assessment | 10 | 2019 | 2434 | 0.810 |
Why?
|
| Aortic Diseases | 4 | 2023 | 87 | 0.800 |
Why?
|
| Heart Failure | 6 | 2018 | 1377 | 0.800 |
Why?
|
| Adolescent | 41 | 2021 | 9550 | 0.790 |
Why?
|
| Heart Valve Prosthesis | 5 | 2017 | 94 | 0.760 |
Why?
|
| Follow-Up Studies | 19 | 2021 | 3815 | 0.760 |
Why?
|
| Heart-Assist Devices | 6 | 2019 | 883 | 0.750 |
Why?
|
| Time Factors | 18 | 2021 | 5380 | 0.740 |
Why?
|
| Forecasting | 3 | 2018 | 288 | 0.710 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2018 | 14 | 0.700 |
Why?
|
| Stents | 1 | 2024 | 406 | 0.690 |
Why?
|
| Balloon Valvuloplasty | 1 | 2021 | 8 | 0.670 |
Why?
|
| Diverticulum | 2 | 2023 | 43 | 0.660 |
Why?
|
| Transposition of Great Vessels | 3 | 2018 | 24 | 0.640 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2020 | 56 | 0.620 |
Why?
|
| Survival Rate | 13 | 2021 | 1945 | 0.610 |
Why?
|
| Infant, Premature, Diseases | 2 | 2018 | 78 | 0.610 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2018 | 66 | 0.580 |
Why?
|
| Nitric Oxide | 1 | 2020 | 281 | 0.570 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2020 | 175 | 0.570 |
Why?
|
| Bioprosthesis | 3 | 2017 | 40 | 0.560 |
Why?
|
| Patient Readmission | 5 | 2020 | 403 | 0.560 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2018 | 26 | 0.550 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2018 | 107 | 0.550 |
Why?
|
| Patient Selection | 3 | 2018 | 688 | 0.540 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2018 | 242 | 0.530 |
Why?
|
| Mitral Valve | 3 | 2020 | 224 | 0.530 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 133 | 0.520 |
Why?
|
| Heart Diseases | 4 | 2013 | 259 | 0.520 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2017 | 21 | 0.510 |
Why?
|
| Coronary Vessels | 4 | 2022 | 175 | 0.510 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2017 | 12 | 0.510 |
Why?
|
| Sinus of Valsalva | 5 | 2012 | 16 | 0.490 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2016 | 14 | 0.490 |
Why?
|
| Databases, Factual | 10 | 2023 | 1004 | 0.490 |
Why?
|
| Aneurysm, False | 4 | 2018 | 52 | 0.490 |
Why?
|
| Risk Factors | 17 | 2021 | 5901 | 0.470 |
Why?
|
| Heart Ventricles | 6 | 2017 | 649 | 0.470 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 75 | 0.460 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 368 | 0.460 |
Why?
|
| Prosthesis Design | 6 | 2018 | 293 | 0.460 |
Why?
|
| ABO Blood-Group System | 3 | 2021 | 58 | 0.450 |
Why?
|
| Vascular Resistance | 2 | 2014 | 97 | 0.440 |
Why?
|
| Sternotomy | 4 | 2016 | 24 | 0.430 |
Why?
|
| Hospital Mortality | 7 | 2019 | 480 | 0.430 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 73 | 0.430 |
Why?
|
| Coronary Aneurysm | 2 | 2018 | 15 | 0.420 |
Why?
|
| Subclavian Artery | 4 | 2023 | 40 | 0.420 |
Why?
|
| Cyanosis | 2 | 2013 | 9 | 0.420 |
Why?
|
| Echocardiography | 8 | 2024 | 748 | 0.420 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2020 | 875 | 0.420 |
Why?
|
| Cryopreservation | 2 | 2012 | 70 | 0.420 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2020 | 55 | 0.410 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 606 | 0.400 |
Why?
|
| Aortic Coarctation | 2 | 2019 | 31 | 0.400 |
Why?
|
| Heart Septal Defects | 2 | 2012 | 28 | 0.390 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2013 | 72 | 0.390 |
Why?
|
| Cardiac Catheterization | 4 | 2020 | 295 | 0.380 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 106 | 0.380 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2022 | 17 | 0.380 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2020 | 58 | 0.380 |
Why?
|
| Autografts | 2 | 2024 | 33 | 0.370 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2022 | 42 | 0.350 |
Why?
|
| Models, Statistical | 1 | 2015 | 584 | 0.350 |
Why?
|
| Tissue Engineering | 3 | 2019 | 202 | 0.350 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 3 | 2020 | 12 | 0.340 |
Why?
|
| Prospective Studies | 11 | 2020 | 4546 | 0.330 |
Why?
|
| Logistic Models | 8 | 2019 | 1241 | 0.320 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2022 | 6 | 0.310 |
Why?
|
| Echocardiography, Doppler | 3 | 2019 | 134 | 0.300 |
Why?
|
| Peptide Fragments | 3 | 2020 | 468 | 0.300 |
Why?
|
| Myocytes, Cardiac | 3 | 2017 | 312 | 0.300 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2009 | 87 | 0.290 |
Why?
|
| Heart Arrest | 2 | 2024 | 310 | 0.290 |
Why?
|
| Blood Group Incompatibility | 1 | 2008 | 22 | 0.280 |
Why?
|
| Adult | 33 | 2022 | 27850 | 0.280 |
Why?
|
| Printing, Three-Dimensional | 3 | 2018 | 50 | 0.280 |
Why?
|
| Truncus Arteriosus | 1 | 2008 | 3 | 0.280 |
Why?
|
| Length of Stay | 5 | 2020 | 820 | 0.280 |
Why?
|
| Extracorporeal Circulation | 2 | 2007 | 37 | 0.280 |
Why?
|
| Survival Analysis | 4 | 2018 | 1518 | 0.280 |
Why?
|
| Young Adult | 12 | 2024 | 6922 | 0.270 |
Why?
|
| Transplantation, Autologous | 3 | 2024 | 359 | 0.270 |
Why?
|
| Computer-Aided Design | 2 | 2018 | 17 | 0.270 |
Why?
|
| Biomarkers | 9 | 2020 | 1905 | 0.270 |
Why?
|
| Models, Anatomic | 2 | 2018 | 87 | 0.270 |
Why?
|
| Recovery of Function | 2 | 2020 | 340 | 0.260 |
Why?
|
| Bioprinting | 2 | 2017 | 14 | 0.260 |
Why?
|
| Dilatation | 2 | 2024 | 45 | 0.250 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 223 | 0.250 |
Why?
|
| Heart-Lung Transplantation | 2 | 2006 | 20 | 0.240 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 72 | 0.240 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2021 | 263 | 0.240 |
Why?
|
| Heart Arrest, Induced | 3 | 2003 | 30 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 4 | 2010 | 229 | 0.230 |
Why?
|
| Lung Transplantation | 2 | 2019 | 367 | 0.230 |
Why?
|
| Cystic Fibrosis | 2 | 2006 | 119 | 0.230 |
Why?
|
| Postoperative Period | 4 | 2019 | 315 | 0.230 |
Why?
|
| Proportional Hazards Models | 5 | 2020 | 889 | 0.220 |
Why?
|
| Perfusion | 2 | 2016 | 260 | 0.220 |
Why?
|
| Galectin 3 | 3 | 2019 | 20 | 0.220 |
Why?
|
| Surgical Flaps | 1 | 2007 | 251 | 0.210 |
Why?
|
| Respiratory Insufficiency | 3 | 2020 | 199 | 0.210 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 148 | 0.210 |
Why?
|
| Registries | 6 | 2021 | 995 | 0.210 |
Why?
|
| Pneumothorax | 3 | 2001 | 51 | 0.200 |
Why?
|
| Courage | 1 | 2023 | 8 | 0.200 |
Why?
|
| Funnel Chest | 2 | 2013 | 8 | 0.200 |
Why?
|
| Resuscitation | 1 | 2024 | 129 | 0.200 |
Why?
|
| Age Factors | 5 | 2018 | 1898 | 0.200 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 1910 | 0.200 |
Why?
|
| Candidiasis | 1 | 2003 | 39 | 0.190 |
Why?
|
| Sternum | 2 | 2013 | 35 | 0.190 |
Why?
|
| Prognosis | 8 | 2020 | 3891 | 0.190 |
Why?
|
| Dilatation, Pathologic | 3 | 2018 | 47 | 0.190 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2003 | 13 | 0.190 |
Why?
|
| Hemodynamics | 5 | 2017 | 712 | 0.190 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2003 | 8 | 0.190 |
Why?
|
| Drainage | 2 | 2019 | 170 | 0.190 |
Why?
|
| Tricuspid Atresia | 1 | 2022 | 4 | 0.190 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2022 | 5 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 258 | 0.190 |
Why?
|
| Foramen Ovale, Patent | 2 | 2017 | 23 | 0.190 |
Why?
|
| Medicine | 1 | 2023 | 93 | 0.180 |
Why?
|
| Prevalence | 4 | 2023 | 1318 | 0.180 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 229 | 0.180 |
Why?
|
| Hypothermia, Induced | 4 | 2013 | 88 | 0.180 |
Why?
|
| Fontan Procedure | 2 | 2017 | 57 | 0.180 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 339 | 0.180 |
Why?
|
| Fatal Outcome | 5 | 2016 | 292 | 0.180 |
Why?
|
| Chest Tubes | 2 | 2001 | 21 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2023 | 117 | 0.180 |
Why?
|
| Shock, Cardiogenic | 1 | 2003 | 168 | 0.170 |
Why?
|
| Societies, Medical | 4 | 2017 | 618 | 0.170 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2001 | 67 | 0.170 |
Why?
|
| Coronary Occlusion | 1 | 2020 | 8 | 0.160 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2020 | 1 | 0.160 |
Why?
|
| Respiratory Paralysis | 1 | 2020 | 9 | 0.160 |
Why?
|
| Ligation | 2 | 2018 | 53 | 0.160 |
Why?
|
| Spheroids, Cellular | 2 | 2017 | 31 | 0.160 |
Why?
|
| Phrenic Nerve | 1 | 2020 | 49 | 0.160 |
Why?
|
| Intraoperative Period | 1 | 2020 | 93 | 0.160 |
Why?
|
| Burns, Inhalation | 1 | 2020 | 4 | 0.160 |
Why?
|
| Formative Feedback | 1 | 2020 | 15 | 0.160 |
Why?
|
| Gynecological Examination | 1 | 2020 | 19 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 203 | 0.150 |
Why?
|
| Diaphragm | 1 | 2020 | 75 | 0.150 |
Why?
|
| Situs Inversus | 2 | 2004 | 16 | 0.150 |
Why?
|
| Scimitar Syndrome | 1 | 2019 | 3 | 0.150 |
Why?
|
| Vascular Malformations | 1 | 2019 | 18 | 0.150 |
Why?
|
| Heart Aneurysm | 1 | 2019 | 16 | 0.150 |
Why?
|
| Illinois | 1 | 2021 | 515 | 0.150 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1999 | 52 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2018 | 2562 | 0.150 |
Why?
|
| Creatinine | 1 | 2020 | 293 | 0.150 |
Why?
|
| Waiting Lists | 2 | 2018 | 211 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2000 | 81 | 0.150 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2017 | 116 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 1999 | 93 | 0.140 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2018 | 2 | 0.140 |
Why?
|
| Maternal Inheritance | 1 | 2018 | 4 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2018 | 66 | 0.140 |
Why?
|
| Mosaicism | 1 | 2018 | 73 | 0.140 |
Why?
|
| Infant, Premature | 2 | 2018 | 293 | 0.140 |
Why?
|
| Obstetrics | 1 | 2020 | 123 | 0.140 |
Why?
|
| North America | 1 | 2018 | 197 | 0.140 |
Why?
|
| Goals | 1 | 2018 | 66 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2020 | 139 | 0.130 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2017 | 4 | 0.130 |
Why?
|
| Patient-Specific Modeling | 1 | 2017 | 24 | 0.130 |
Why?
|
| Ultrasonography | 5 | 2009 | 679 | 0.130 |
Why?
|
| Fetoscopy | 1 | 2017 | 9 | 0.130 |
Why?
|
| Arterial Switch Operation | 1 | 2017 | 5 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 71 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 300 | 0.130 |
Why?
|
| Rewarming | 2 | 2016 | 5 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1704 | 0.130 |
Why?
|
| Hypotension | 3 | 2014 | 71 | 0.130 |
Why?
|
| Fetal Diseases | 1 | 2017 | 71 | 0.130 |
Why?
|
| Virtual Reality | 1 | 2018 | 37 | 0.130 |
Why?
|
| Propensity Score | 1 | 2018 | 178 | 0.130 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 985 | 0.130 |
Why?
|
| Oxygenators, Membrane | 1 | 2016 | 3 | 0.130 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2018 | 267 | 0.120 |
Why?
|
| Wound Closure Techniques | 1 | 2016 | 15 | 0.120 |
Why?
|
| Homeostasis | 2 | 2010 | 459 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2018 | 171 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 63 | 0.120 |
Why?
|
| Simulation Training | 1 | 2018 | 107 | 0.120 |
Why?
|
| Intestines | 1 | 1999 | 433 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2019 | 282 | 0.120 |
Why?
|
| Trachea | 1 | 2017 | 245 | 0.120 |
Why?
|
| Health Status | 1 | 2018 | 373 | 0.120 |
Why?
|
| Brachiocephalic Trunk | 2 | 2007 | 14 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1908 | 0.120 |
Why?
|
| Cardiology | 1 | 2017 | 120 | 0.120 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1727 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 128 | 0.120 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 201 | 0.120 |
Why?
|
| Thrombosis | 1 | 2019 | 308 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2016 | 67 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2019 | 3044 | 0.120 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2016 | 62 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 135 | 0.110 |
Why?
|
| Middle Aged | 17 | 2019 | 27539 | 0.110 |
Why?
|
| Mutation | 5 | 2014 | 4265 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 346 | 0.110 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2023 | 7 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2014 | 41 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 96 | 0.100 |
Why?
|
| United States | 5 | 2019 | 7581 | 0.100 |
Why?
|
| Tissue Donors | 2 | 2008 | 541 | 0.100 |
Why?
|
| Organ Sparing Treatments | 2 | 2024 | 48 | 0.100 |
Why?
|
| Lung | 2 | 2019 | 1359 | 0.090 |
Why?
|
| Measles virus | 1 | 2012 | 9 | 0.090 |
Why?
|
| Endocarditis | 2 | 2016 | 24 | 0.090 |
Why?
|
| Measles | 1 | 2012 | 13 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2014 | 709 | 0.090 |
Why?
|
| Thymocytes | 1 | 2012 | 31 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2013 | 312 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 2 | 2010 | 112 | 0.090 |
Why?
|
| Peritoneal Dialysis | 1 | 1992 | 30 | 0.090 |
Why?
|
| Prosthesis Fitting | 1 | 2011 | 17 | 0.090 |
Why?
|
| Polyethylene Terephthalates | 1 | 2011 | 19 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2012 | 99 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2012 | 196 | 0.090 |
Why?
|
| Vena Cava, Superior | 2 | 2009 | 54 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 51 | 0.090 |
Why?
|
| Pregnancy | 4 | 2020 | 3128 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1611 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2008 | 65 | 0.080 |
Why?
|
| Baltimore | 1 | 2010 | 41 | 0.080 |
Why?
|
| Anastomosis, Surgical | 2 | 2009 | 280 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1074 | 0.080 |
Why?
|
| Heart Atria | 2 | 2020 | 247 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3450 | 0.080 |
Why?
|
| Oximetry | 2 | 2010 | 88 | 0.080 |
Why?
|
| Myocardium | 3 | 2018 | 567 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 147 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2010 | 41 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 109 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2011 | 294 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1719 | 0.080 |
Why?
|
| Seasons | 1 | 2011 | 239 | 0.080 |
Why?
|
| Maryland | 2 | 2019 | 45 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2020 | 133 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2001 | 24 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 481 | 0.070 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2010 | 81 | 0.070 |
Why?
|
| Cardiac Tamponade | 1 | 2009 | 19 | 0.070 |
Why?
|
| Proteins | 1 | 2014 | 790 | 0.070 |
Why?
|
| Palliative Care | 3 | 2007 | 268 | 0.070 |
Why?
|
| Histocompatibility Testing | 1 | 2008 | 140 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 660 | 0.070 |
Why?
|
| Heart Bypass, Right | 1 | 2008 | 12 | 0.070 |
Why?
|
| Incidence | 3 | 2020 | 1697 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1231 | 0.070 |
Why?
|
| Device Removal | 1 | 2009 | 166 | 0.070 |
Why?
|
| Syndrome | 3 | 2019 | 432 | 0.070 |
Why?
|
| Sepsis | 2 | 2016 | 382 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2007 | 30 | 0.070 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2009 | 151 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2008 | 573 | 0.060 |
Why?
|
| Aneurysm | 1 | 2007 | 57 | 0.060 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 162 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2008 | 135 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2017 | 913 | 0.060 |
Why?
|
| Down Syndrome | 2 | 2006 | 50 | 0.060 |
Why?
|
| Europe | 2 | 2017 | 338 | 0.060 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2006 | 2 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2007 | 116 | 0.060 |
Why?
|
| Haemophilus Infections | 1 | 2006 | 8 | 0.060 |
Why?
|
| Pericarditis | 1 | 2006 | 14 | 0.060 |
Why?
|
| Haemophilus influenzae | 1 | 2006 | 15 | 0.060 |
Why?
|
| Compartment Syndromes | 1 | 2006 | 17 | 0.060 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 1014 | 0.060 |
Why?
|
| Troponin T | 1 | 2006 | 41 | 0.060 |
Why?
|
| Abdomen | 1 | 2006 | 118 | 0.060 |
Why?
|
| Medical Records | 1 | 2005 | 121 | 0.060 |
Why?
|
| Catheterization | 2 | 2003 | 217 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 272 | 0.050 |
Why?
|
| Pulmonary Atresia | 1 | 2004 | 12 | 0.050 |
Why?
|
| Hepatic Veins | 1 | 2004 | 25 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2004 | 95 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 517 | 0.050 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 2001 | 16 | 0.050 |
Why?
|
| Thoracostomy | 2 | 2001 | 10 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2005 | 137 | 0.050 |
Why?
|
| Pleurodesis | 2 | 2001 | 9 | 0.050 |
Why?
|
| Arteriovenous Fistula | 1 | 2004 | 52 | 0.050 |
Why?
|
| Recurrence | 1 | 2007 | 1188 | 0.050 |
Why?
|
| Sheep | 1 | 2003 | 203 | 0.050 |
Why?
|
| Medical Illustration | 1 | 2023 | 14 | 0.050 |
Why?
|
| Flucytosine | 1 | 2003 | 10 | 0.050 |
Why?
|
| Amphotericin B | 1 | 2003 | 33 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2004 | 135 | 0.050 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 22 | 0.050 |
Why?
|
| Equipment Design | 2 | 2019 | 411 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2003 | 94 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2003 | 122 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 280 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 139 | 0.040 |
Why?
|
| Perioperative Care | 2 | 2019 | 187 | 0.040 |
Why?
|
| Oxygen | 1 | 2007 | 749 | 0.040 |
Why?
|
| Body Weight | 1 | 2003 | 449 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2002 | 35 | 0.040 |
Why?
|
| Bronchial Fistula | 1 | 2001 | 10 | 0.040 |
Why?
|
| Respiratory Tract Fistula | 1 | 2001 | 9 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2016 | 117 | 0.040 |
Why?
|
| Pleural Diseases | 1 | 2001 | 15 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2003 | 220 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2018 | 232 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2705 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1786 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2014 | 404 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2827 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 257 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2002 | 159 | 0.040 |
Why?
|
| Labor Stage, First | 1 | 2020 | 3 | 0.040 |
Why?
|
| Labor Presentation | 1 | 2020 | 4 | 0.040 |
Why?
|
| Animals | 5 | 2019 | 27973 | 0.040 |
Why?
|
| Cholecystitis | 1 | 1999 | 17 | 0.040 |
Why?
|
| Galectins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Head | 1 | 2020 | 131 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2003 | 357 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 29 | 0.040 |
Why?
|
| Infusion Pumps | 1 | 2019 | 25 | 0.040 |
Why?
|
| Risk Management | 1 | 2019 | 38 | 0.040 |
Why?
|
| Cardioplegic Solutions | 1 | 2019 | 17 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2019 | 144 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 191 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 126 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2002 | 418 | 0.040 |
Why?
|
| Albumins | 1 | 2019 | 123 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2000 | 163 | 0.030 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 56 | 0.030 |
Why?
|
| Cause of Death | 2 | 2009 | 271 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 360 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 207 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2003 | 531 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 499 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2017 | 20 | 0.030 |
Why?
|
| Graft Survival | 1 | 2021 | 939 | 0.030 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2017 | 92 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 107 | 0.030 |
Why?
|
| Polymers | 1 | 2019 | 217 | 0.030 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 28 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 92 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 76 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 49 | 0.030 |
Why?
|
| Pulmonary Atelectasis | 1 | 1997 | 19 | 0.030 |
Why?
|
| Injections | 1 | 2017 | 121 | 0.030 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2008 | 9 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 774 | 0.030 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 296 | 0.030 |
Why?
|
| Mediastinitis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 1997 | 53 | 0.030 |
Why?
|
| Thoracic Surgery | 1 | 2017 | 62 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2016 | 37 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 6 | 0.030 |
Why?
|
| Brain | 1 | 2007 | 2337 | 0.030 |
Why?
|
| Gestational Age | 1 | 2017 | 328 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 145 | 0.030 |
Why?
|
| Tunica Media | 1 | 2016 | 16 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2019 | 350 | 0.030 |
Why?
|
| Aortography | 1 | 2016 | 57 | 0.030 |
Why?
|
| Developing Countries | 1 | 2016 | 91 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2021 | 1123 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 226 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 23 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 381 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2016 | 137 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 887 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 42 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 175 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1304 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2020 | 810 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 477 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 67 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2017 | 752 | 0.030 |
Why?
|
| Software | 1 | 2018 | 669 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 236 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 355 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1102 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1171 | 0.020 |
Why?
|
| Tetraspanin 24 | 1 | 2012 | 5 | 0.020 |
Why?
|
| Measles Vaccine | 1 | 2012 | 8 | 0.020 |
Why?
|
| Operative Time | 1 | 2013 | 167 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 120 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 515 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 885 | 0.020 |
Why?
|
| Surgeons | 1 | 2016 | 292 | 0.020 |
Why?
|
| Epinephrine | 1 | 2011 | 92 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 409 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1992 | 240 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 4028 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2011 | 87 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 156 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 2545 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 459 | 0.020 |
Why?
|
| Dopamine | 1 | 2011 | 276 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 177 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 2889 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2009 | 25 | 0.020 |
Why?
|
| Warm Ischemia | 1 | 2009 | 33 | 0.020 |
Why?
|
| Aged | 3 | 2014 | 20398 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1529 | 0.020 |
Why?
|
| Survivors | 1 | 2009 | 204 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 371 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 127 | 0.020 |
Why?
|
| Siblings | 1 | 2008 | 108 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2008 | 122 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2007 | 52 | 0.020 |
Why?
|
| Serotyping | 1 | 2006 | 28 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1160 | 0.010 |
Why?
|
| Myosins | 1 | 2006 | 86 | 0.010 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2007 | 119 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 75 | 0.010 |
Why?
|
| Hemorheology | 1 | 2004 | 8 | 0.010 |
Why?
|
| Venae Cavae | 1 | 2004 | 12 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 323 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 121 | 0.010 |
Why?
|
| Tourniquets | 1 | 2003 | 10 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2003 | 57 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2006 | 562 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2003 | 71 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 52 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2006 | 660 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2003 | 139 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 1866 | 0.010 |
Why?
|
| Bronchoscopes | 1 | 2002 | 4 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 306 | 0.010 |
Why?
|
| Methyl Ethers | 1 | 2002 | 33 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 2002 | 32 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 647 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 430 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 95 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2003 | 278 | 0.010 |
Why?
|
| Goats | 1 | 2000 | 16 | 0.010 |
Why?
|
| Bronchi | 1 | 2002 | 224 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 12230 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 392 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 748 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 1269 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 1997 | 49 | 0.010 |
Why?
|
| Sclerotherapy | 1 | 1996 | 16 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1996 | 68 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1997 | 148 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 7039 | 0.010 |
Why?
|